# A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa

> **NCT00458575** · PHASE1 · TERMINATED · sponsor: **Centocor, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DRUG:** CNTO 2476

## Key facts

- **NCT ID:** NCT00458575
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Internal Business Decision
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458575, "A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00458575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*